|
1
|
Trabectedin plus pegylated liposomal Doxorubicin in recurrent ovarian cancer.
|
J Clin Oncol
|
2010
|
3.33
|
|
2
|
The impact of tumor morcellation during surgery on the prognosis of patients with apparently early uterine leiomyosarcoma.
|
Gynecol Oncol
|
2011
|
2.76
|
|
3
|
Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes.
|
Gynecol Oncol
|
2008
|
1.89
|
|
4
|
Laparoscopic management of early uterine cancer: 10-year experience in Asan Medical Center.
|
Gynecol Oncol
|
2007
|
1.81
|
|
5
|
Progestin re-treatment in patients with recurrent endometrial adenocarcinoma after successful fertility-sparing management using progestin.
|
Gynecol Oncol
|
2012
|
1.49
|
|
6
|
Prospective randomized comparison of monthly fluorouracil and cisplatin versus weekly cisplatin concurrent with pelvic radiotherapy and high-dose rate brachytherapy for locally advanced cervical cancer.
|
Gynecol Oncol
|
2007
|
1.23
|
|
7
|
Malignant transformation of mature cystic teratoma of the ovary: experience at a single institution.
|
Eur J Obstet Gynecol Reprod Biol
|
2008
|
1.09
|
|
8
|
Surgical management of borderline ovarian tumors: The role of fertility-sparing surgery.
|
Gynecol Oncol
|
2009
|
1.06
|
|
9
|
Stage IIIC epithelial ovarian cancer classified solely by lymph node metastasis has a more favorable prognosis than other types of stage IIIC epithelial ovarian cancer.
|
J Gynecol Oncol
|
2008
|
1.06
|
|
10
|
Prognostic factors and treatment outcomes of patients with uterine sarcoma: analysis of 127 patients at a single institution, 1989-2007.
|
J Cancer Res Clin Oncol
|
2008
|
1.05
|
|
11
|
Comparison of the validity of magnetic resonance imaging and positron emission tomography/computed tomography in the preoperative evaluation of patients with uterine corpus cancer.
|
Gynecol Oncol
|
2008
|
1.04
|
|
12
|
The impact of tumor morcellation during surgery on the outcomes of patients with apparently early low-grade endometrial stromal sarcoma of the uterus.
|
Ann Surg Oncol
|
2011
|
1.03
|
|
13
|
Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition.
|
J Gynecol Oncol
|
2013
|
1.02
|
|
14
|
Expression profile of histone deacetylases 1, 2 and 3 in ovarian cancer tissues.
|
J Gynecol Oncol
|
2008
|
0.99
|
|
15
|
Is complete surgical staging necessary in patients with stage I mucinous epithelial ovarian tumors?
|
Gynecol Oncol
|
2006
|
0.98
|
|
16
|
Further stratification of risk groups in patients with lymph node metastasis after radical hysterectomy for early-stage cervical cancer.
|
Gynecol Oncol
|
2010
|
0.97
|
|
17
|
The use of HE4 in the prediction of ovarian cancer in Asian women with a pelvic mass.
|
Gynecol Oncol
|
2012
|
0.96
|
|
18
|
Menthol regulates TRPM8-independent processes in PC-3 prostate cancer cells.
|
Biochim Biophys Acta
|
2008
|
0.96
|
|
19
|
Neoadjuvant chemotherapy with paclitaxel plus platinum followed by radical surgery in early cervical cancer during pregnancy: three case reports.
|
Jpn J Clin Oncol
|
2010
|
0.95
|
|
20
|
Laparoscopic versus open radical hysterectomy in patients with stage IB2 and IIA2 cervical cancer.
|
J Surg Oncol
|
2013
|
0.94
|
|
21
|
Vaginal cuff dehiscence after hysterectomy.
|
Int J Gynaecol Obstet
|
2013
|
0.94
|
|
22
|
Peroxiredoxin 6 overexpression attenuates cisplatin-induced apoptosis in human ovarian cancer cells.
|
Cancer Invest
|
2011
|
0.94
|
|
23
|
Comparison of laparoscopy and laparotomy in surgical staging of early-stage ovarian and fallopian tubal cancer.
|
Ann Surg Oncol
|
2008
|
0.94
|
|
24
|
Differential gene expression profiling in human cholangiocarcinoma cells treated with Clonorchis sinensis excretory-secretory products.
|
Parasitol Res
|
2008
|
0.93
|
|
25
|
Surgical staging and adjuvant chemotherapy in the management of patients with adult granulosa cell tumors of the ovary.
|
Gynecol Oncol
|
2011
|
0.93
|
|
26
|
Comparison of outcomes between radical hysterectomy followed by tailored adjuvant therapy versus primary chemoradiation therapy in IB2 and IIA2 cervical cancer.
|
J Gynecol Oncol
|
2012
|
0.93
|
|
27
|
High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.92
|
|
28
|
Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study.
|
Gynecol Oncol
|
2013
|
0.91
|
|
29
|
Unfavorable prognosis of small cell neuroendocrine carcinoma of the uterine cervix: a retrospective matched case-control study.
|
Int J Gynecol Cancer
|
2010
|
0.91
|
|
30
|
Vaccination with a human papillomavirus (HPV)-16/18 AS04-adjuvanted cervical cancer vaccine in Korean girls aged 10-14 years.
|
J Korean Med Sci
|
2010
|
0.91
|
|
31
|
Risk assessment tool for distant recurrence after platinum-based concurrent chemoradiation in patients with locally advanced cervical cancer: a Korean gynecologic oncology group study.
|
J Clin Oncol
|
2012
|
0.91
|
|
32
|
A low-risk group for lymph node metastasis is accurately identified by Korean gynecologic oncology group criteria in two Japanese cohorts with endometrial cancer.
|
Gynecol Oncol
|
2013
|
0.91
|
|
33
|
Laparoscopic versus open radical hysterectomy for elderly patients with early-stage cervical cancer.
|
Am J Obstet Gynecol
|
2012
|
0.90
|
|
34
|
Pregnancy outcomes after fertility-sparing management in young women with early endometrial cancer.
|
Obstet Gynecol
|
2013
|
0.90
|
|
35
|
Efficacy of taxane and platinum-based chemotherapy guided by extreme drug resistance assay in patients with epithelial ovarian cancer.
|
J Gynecol Oncol
|
2009
|
0.89
|
|
36
|
The efficacy of conservative management after conization in patients with stage IA1 microinvasive cervical carcinoma.
|
Acta Obstet Gynecol Scand
|
2009
|
0.89
|
|
37
|
Long-term outcomes after fertility-sparing laparoscopic radical trachelectomy in young women with early-stage cervical cancer: an Asan Gynecologic Cancer Group (AGCG) study.
|
J Surg Oncol
|
2014
|
0.88
|
|
38
|
Clinical presentation of endometrioid epithelial ovarian cancer with concurrent endometriosis: a multicenter retrospective study.
|
Cancer Epidemiol Biomarkers Prev
|
2010
|
0.88
|
|
39
|
The effect of combined treatment with cisplatin and histone deacetylase inhibitors on HeLa cells.
|
J Gynecol Oncol
|
2010
|
0.87
|
|
40
|
Role of PET or PET/CT in the post-therapy surveillance of uterine sarcoma.
|
Gynecol Oncol
|
2008
|
0.86
|
|
41
|
Pure primary squamous cell carcinoma of the ovary: a report of two cases and review of the literature.
|
Int J Gynecol Pathol
|
2010
|
0.86
|
|
42
|
Long-term oncologic outcomes after fertility-sparing management using oral progestin for young women with endometrial cancer (KGOG 2002).
|
Eur J Cancer
|
2012
|
0.86
|
|
43
|
The role of pelvic and/or para-aortic lymphadenectomy in surgical management of apparently early carcinosarcoma of uterus.
|
Ann Surg Oncol
|
2010
|
0.85
|
|
44
|
Radiation therapy is a treatment to be considered for recurrent epithelial ovarian cancer after chemotherapy.
|
Tumori
|
2011
|
0.85
|
|
45
|
The relationship between cisplatin resistance and histone deacetylase isoform overexpression in epithelial ovarian cancer cell lines.
|
J Gynecol Oncol
|
2012
|
0.85
|
|
46
|
Progression-free survival is accurately predicted in patients treated with chemotherapy for epithelial ovarian cancer by the histoculture drug response assay in a prospective correlative clinical trial at a single institution.
|
Anticancer Res
|
2013
|
0.85
|
|
47
|
Endometrial stromal tumor with limited infiltration and probable extrauterine metastasis: report of a case.
|
Ann Diagn Pathol
|
2005
|
0.85
|
|
48
|
Proliferation of CD4CD25Foxp3 regulatory T lymphocytes in ex vivo expanded ascitic fluid from primary and recurrent ovarian carcinoma.
|
J Gynecol Oncol
|
2010
|
0.85
|
|
49
|
Is chemotherapy-induced neutropenia a prognostic factor in patients with ovarian cancer?
|
Acta Obstet Gynecol Scand
|
2010
|
0.84
|
|
50
|
Micropapillary pattern in serous borderline ovarian tumors: does it matter?
|
Gynecol Oncol
|
2011
|
0.84
|
|
51
|
Fatal Ifosfamide-induced metabolic encephalopathy in patients with recurrent epithelial ovarian cancer: report of two cases.
|
Cancer Res Treat
|
2011
|
0.83
|
|
52
|
Laparoscopic compared with open radical hysterectomy in obese women with early-stage cervical cancer.
|
Obstet Gynecol
|
2012
|
0.83
|
|
53
|
Identification of differentially expressed microRNAs in endometrial cancer cells after progesterone treatment.
|
Int J Gynecol Cancer
|
2012
|
0.83
|
|
54
|
Human papillomavirus test after conization in predicting residual disease in subsequent hysterectomy specimens.
|
Obstet Gynecol
|
2009
|
0.83
|
|
55
|
Secondary cytoreductive surgery in the management of platinum-sensitive recurrent epithelial ovarian cancer.
|
J Surg Oncol
|
2010
|
0.83
|
|
56
|
Cervical cancer patient information-seeking behaviors, information needs, and information sources in South Korea.
|
Support Care Cancer
|
2009
|
0.82
|
|
57
|
Comparative study of neoadjuvant chemotherapy before radical hysterectomy and radical surgery alone in stage IB2-IIA bulky cervical cancer.
|
J Gynecol Oncol
|
2009
|
0.82
|
|
58
|
Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy.
|
Gynecol Oncol
|
2012
|
0.82
|
|
59
|
Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver.
|
Arch Gynecol Obstet
|
2010
|
0.82
|
|
60
|
In vitro chemosensitivity using the histoculture drug response assay in human epithelial ovarian cancer.
|
Acta Med Okayama
|
2012
|
0.82
|
|
61
|
Hormonal therapy for women with stage IA endometrial cancer of all grades.
|
Obstet Gynecol
|
2013
|
0.81
|
|
62
|
Uterine artery-preserving laparoscopic radical trachelectomy for early cervical cancer: technical aspects.
|
Gynecol Oncol
|
2012
|
0.81
|
|
63
|
A preliminary results of a randomized trial comparing monthly 5-flourouracil and cisplatin to weekly cisplatin alone combined with concurrent radiotherapy for locally advanced cervical cancer.
|
Cancer Res Treat
|
2005
|
0.81
|
|
64
|
Laparoendoscopic single-site versus conventional laparoscopic surgical staging for early-stage endometrial cancer.
|
Int J Gynecol Cancer
|
2014
|
0.81
|
|
65
|
Asian society of gynecologic oncology workshop 2010.
|
J Gynecol Oncol
|
2010
|
0.81
|
|
66
|
Concurrent chemoradiotherapy or radiotherapy alone for locally advanced cervical cancer in elderly women.
|
Tumori
|
2011
|
0.81
|
|
67
|
Sister Society Meeting on Global Education Development and Collaboration: Meeting Report.
|
Int J Gynecol Cancer
|
2016
|
0.81
|
|
68
|
Ex vivo expansion of human umbilical cord blood-derived T-lymphocytes with homologous cord blood plasma.
|
Tohoku J Exp Med
|
2005
|
0.80
|
|
69
|
Prognostic significance of stromal microinvasion in the intestinal type of ovarian mucinous adenocarcinoma.
|
Ann Surg Oncol
|
2011
|
0.79
|
|
70
|
Clear cell adenocarcinoma arising in endometriosis of a previous episiotomy site.
|
Obstet Gynecol
|
2008
|
0.79
|
|
71
|
Laparoscopic management of early-stage malignant nonepithelial ovarian tumors: surgical and survival outcomes.
|
Int J Gynecol Cancer
|
2013
|
0.79
|
|
72
|
Feasibility and outcome of concurrent chemoradiotherapy for recurrent cervical carcinoma after initial surgery.
|
Tumori
|
2010
|
0.79
|
|
73
|
Immunohistochemical analysis for therapeutic targets and prognostic markers in low-grade endometrial stromal sarcoma.
|
Int J Gynecol Cancer
|
2013
|
0.79
|
|
74
|
Long-term outcomes of concomitant chemoradiotherapy incorporating high-dose-rate brachytherapy to treat locally advanced cervical cancer.
|
Tumori
|
2012
|
0.79
|
|
75
|
Preoperative fluorine 18 fluorodeoxyglucose tumoral uptake ratio between upper and lower abdomen in primary advanced-stage ovarian cancer.
|
Int J Gynecol Cancer
|
2013
|
0.78
|
|
76
|
Mutational analysis of KRAS, BRAF, and TP53 genes of ovarian serous carcinomas in Korean women.
|
Yonsei Med J
|
2009
|
0.78
|
|
77
|
The role of loop electrosurgical excisional procedure in the management of adenocarcinoma in situ of the uterine cervix.
|
Eur J Obstet Gynecol Reprod Biol
|
2009
|
0.78
|
|
78
|
Optimal debulking surgery followed by paclitaxel/platinum chemotherapy is very effective in treating ovarian carcinosarcomas: a single center experience.
|
Gynecol Obstet Invest
|
2011
|
0.78
|
|
79
|
Poor prognosis of uterine serous carcinoma compared with grade 3 endometrioid carcinoma in early stage patients.
|
Virchows Arch
|
2013
|
0.78
|
|
80
|
Individualized prediction of overall survival after postoperative radiation therapy in patients with early-stage cervical cancer: a Korean Radiation Oncology Group study (KROG 13-03).
|
Int J Radiat Oncol Biol Phys
|
2013
|
0.78
|
|
81
|
Outcomes of Surgery Alone and Surveillance Strategy in Young Women With Stage I Malignant Ovarian Germ Cell Tumors.
|
Int J Gynecol Cancer
|
2016
|
0.78
|
|
82
|
Chemosensitivity of uterine cervical cancer demonstrated by the histoculture drug response assay.
|
Tohoku J Exp Med
|
2009
|
0.77
|
|
83
|
Pure basaloid squamous cell carcinoma of the uterine cervix: a case report.
|
J Korean Med Sci
|
2009
|
0.77
|
|
84
|
Laparotomy conversion rate of laparoscopic radical hysterectomy for early-stage cervical cancer in a consecutive series without case selection.
|
Ann Surg Oncol
|
2014
|
0.77
|
|
85
|
Use of complex surgical procedures, patterns of tumor spread, and CA-125 predicts a risk of incomplete cytoreduction: a Korean Gynecologic Oncology Group study (KGOG-3022).
|
Gynecol Oncol
|
2013
|
0.77
|
|
86
|
A multicenter study of the importance of systemic chemotherapy for patients with small-cell neuroendocrine carcinoma of the uterine cervix.
|
Gynecol Obstet Invest
|
2014
|
0.77
|
|
87
|
Transcriptional regulation of the murine 1-cys peroxiredoxin gene by the B cell-specific activator protein, Pax5.
|
J Cell Biochem
|
2008
|
0.77
|
|
88
|
The efficacy and toxicity of belotecan (CKD-602), a camptothericin analogue topoisomerase I inhibitor, in patients with recurrent or refractory epithelial ovarian cancer.
|
J Chemother
|
2010
|
0.77
|
|
89
|
Phase II evaluation of CKD-602, a camptothecin analog, administered on a 5-day schedule to patients with platinum-sensitive or -resistant ovarian cancer.
|
Gynecol Oncol
|
2008
|
0.77
|
|
90
|
Laparoendoscopic single-site versus conventional laparoscopic-assisted vaginal hysterectomy for benign or pre-invasive uterine disease.
|
Surg Endosc
|
2014
|
0.76
|
|
91
|
A comparative study of outside-in and inside-out transobturator tape procedures for stress urinary incontinence.
|
Gynecol Obstet Invest
|
2010
|
0.76
|
|
92
|
Reliability of magnetic resonance imaging in assessing myometrial invasion absence in endometrial carcinoma.
|
Acta Obstet Gynecol Scand
|
2009
|
0.76
|
|
93
|
Postoperative acute renal failure in patients with gynecologic malignancies: analysis of 10 cases and review of the literature.
|
J Gynecol Oncol
|
2009
|
0.75
|
|
94
|
Paratubal serous borderline tumor.
|
J Gynecol Oncol
|
2011
|
0.75
|
|
95
|
Hexamethylmelamine as consolidation treatment for patients with advanced epithelial ovarian cancer in complete response after first-line chemotherapy.
|
J Korean Med Sci
|
2009
|
0.75
|
|
96
|
Identification of a preoperative predictive factor for lymph node metastasis in uterine papillary serous carcinoma: long-term results from a single institution.
|
Int J Gynecol Cancer
|
2015
|
0.75
|
|
97
|
Stratification of risk groups according to survival after recurrence in endometrial cancer patients.
|
Medicine (Baltimore)
|
2017
|
0.75
|
|
98
|
Paget's disease of the vulva: evaluation of recurrence relative to symptom duration, volumetric excision of lesion, and surgical margin status.
|
Acta Obstet Gynecol Scand
|
2010
|
0.75
|
|
99
|
Preoperative Predictive Factors for Complete Cytoreduction and Survival Outcome in Epithelial Ovarian, Tubal, and Peritoneal Cancer After Neoadjuvant Chemotherapy.
|
Int J Gynecol Cancer
|
2017
|
0.75
|
|
100
|
A distinctive fatty acid profile in circulating lipids of Korean gestational diabetics: a pilot study.
|
Diabetes Res Clin Pract
|
2006
|
0.75
|
|
101
|
Recognition of parametrial invasion, an important landmark when treating cervical cancer.
|
Gynecol Oncol
|
2011
|
0.75
|
|
102
|
Erratum: Author correction.
|
Obstet Gynecol Sci
|
2017
|
0.75
|
|
103
|
Significance of Ovarian Endometriosis on the Prognosis of Ovarian Clear Cell Carcinoma.
|
Int J Gynecol Cancer
|
2017
|
0.75
|
|
104
|
Investigation of New Therapeutic Targets in Undifferentiated Endometrial Sarcoma.
|
Gynecol Obstet Invest
|
2017
|
0.75
|
|
105
|
A Long-term follow-up study of 91 cases with ovarian granulosa cell tumors.
|
Anticancer Res
|
2014
|
0.75
|
|
106
|
Cost-Efficiency of Robotic Surgery.
|
Int J Gynecol Cancer
|
2016
|
0.75
|